Novartis chief criticises EU move to control pharma licensing in emergencies | Financial Times
Can Novartis Digitally Transform Clinical Development? - TimmermanReport.com
Basel is very open to newcomers - Basel Area Business & Innovation
novartis: Who is Vas Narasimhan? All about the new global chief executive of Swiss pharma giant Novartis - The Economic Times
Novartis to pay $9.7bn in bet on novel technology - Gulf Times
Novartis CEO Vas Narasimhan: How to be a boss in an “unbossed” company - YouTube
Supplies from China stable for now, but monitoring situation: Novartis' Vas Narasimhan - The Hindu BusinessLine
Novartis's Vas Narasimhan on AI, Data Science for Company Operations
Novartis CEO's $50 Billion of Deals Was Just the First Act - Bloomberg
Novartis' CEO is “un-bossing” his 125,000 employees
Vas Narasimhan (@VasNarasimhan) / Twitter
Vasant Narasimhan to Succeed Joseph Jimenez as CEO Novartis - IndiaMedToday
Novartis CEO's 2020 pay drops to $11.6M, no thanks to COVID-19's drag on sales | Fierce Pharma
Cannabinoids are not a focus area" Novartis CEO
How Novartis Is Finding The Path To Be A Digital Winner
New Novartis chief eyes productivity revolution - SWI swissinfo.ch
Novartis CEO Who Wanted To Bring Tech Into Pharma Now Explains Why It's So Hard
Vas Narasimhan knew what to expect as Novartis CEO—or so he thought: NYT | Fierce Pharma
Vasant Narasimhan | Novartis
Novartis CEO Says FDA Process Could Have Been Handled Better - Bloomberg
Novartis CEO Battles Fallout From Data Manipulation - WSJ
Novartis C.E.O. Defends Company's Decision to Withhold False Data From the F.D.A. - The New York Times
Novartis CEO On How Yoga & Lessons From His Grandparents Help In Taking Big Professional Decisions - YouTube
Vasant Narasimhan - Wikipedia
Novartis CEO Continues Shake-Up, Says Will Save More Than $1 Billion Annually | Barron's
Vas Narasimhan: the American trying to reshape Novartis | Financial Times
